The acute effects of azithromycin use on cardiovascular mortality, as compared with amoxicillin

Study identification

• EU PAS number:
  EUPAS9449
• Study ID:
  37446
• Official title and acronym:
  The acute effects of azithromycin use on cardiovascular mortality, as compared with amoxicillin
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  No information provided.
• Study status:
  Finalised

Study timelines

Date when funding contract was signed

Planned:16/08/2014

Actual:16/08/2014

Study start date

Planned:30/04/2015

Actual:16/04/2015

Date of final study report

Planned:30/11/2016

Actual:14/11/2018

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Pfizer Inc.

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)